Best Practice & Research Clinical Haematology
Volume 19, Issue 4 , Pages 737-755, December 2006

Donor leukocyte infusions in myeloid malignancies: new strategies

  • David L. Porter, MD (Director, Allogeneic Stem Cell Transplantation, and Associate Professor of Medicine)

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: +1 215 662 2867; Fax: +1 215 662 4064.
  • Joseph H. Antin, MD (Chief, Stem Cell Transplantation Program, and Professor of Medicine)

University of Pennsylvania Medical Center, 16 Penn Tower, 3400 Spruce St, Philadelphia, PA 19104, USA

Harvard Medical School, Dana-Farber Cancer Institute and Brigham and Women's Hospital, 44 Binney St, Boston, MA 02115, USA

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1521-6926(06)00035-1

doi:10.1016/j.beha.2006.05.003

Best Practice & Research Clinical Haematology
Volume 19, Issue 4 , Pages 737-755, December 2006

Article Tools

* Image Usage & Resolution